Search filters

Filters
Clear All

Phase

  • 18
  • 63
  • 42
  • 80
  • 13
  • 93
  • 13
  • 581
  • 934
  • 404
  • 12
  • 45
  • 881
  • 931
  • 7
  • 20
  • 918

Found 938 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
18 years - 100 years
Accepts healthy volunteer
All genders
We are looking for healthy volunteers to donate bone marrow for research purposes. The Stem Cell & Xenograft Core provides bone marrow to laboratories on Penn’s campus researching leukemia and other blood disorders
Quality Improvement Assessment for Patient-Centered Community Health Worker Intervention
18 years - 99 years
All genders
The purpose of the IMPaCT Transitions program is to help low-income general medicine patients who have been cared for at the Hospital of the University of Pennsylvania or Presbyterian Hospital with the transition from hospital to a primary care clinic. The purpose of IMPaCT Home is to help low-SES patients …
UPCC 21317 Detection of Cell-Free Circulating Tumor DNA in Patients with Histopathologically/Molecularly Proven or Radiographically Suspected Glial Tumors
99 years or below
All genders
Glioblastoma (GBM) is the most common primary brain tumor in adults and is uniformly fatal. During standard adjuvant treatment for GBM following initial surgical resection of the tumor, patients are treated with a combination of radiation and chemotherapy. During and after this adjuvant treatment, patients are monitored for disease progression …
Percutaneous Muscle Biopsy
18 years - 90 years
Accepts healthy volunteer
All genders
The Percutaneous Muscle Biopsy Study is being conducted to learn about the differences in muscle tissue from patients with heart failure, hypertension, or a mitochondrial disorder compared to healthy patients. Patients undergo a biopsy of their thigh, which is a quick procedure involving a small cut through the skin. The …
UPCC 34217 Analysis of Primary and Metastatic Colorectal Cancer
99 years or below
All genders
Colorectal cancer is amongst the top three leading causes of cancer and likewise, the third leading cause of cancer related mortality. In particular, there are limited therapeutic options for stage IV or metastatic CRC (to liver, lungs, and other sites), with 5-year survival being less than 10%. While preclinical model …
UPCC 44417 Long-Term Follow-Up Protocol for Subjects Treated with Gene-Modified T Cells
All genders
Phase 2/3
Interventional
This study investigates the long-term safety and efficacy of gene-modified T-cell therapy in both children and adults. The purpose is to observe participants who have previously received this therapy in a Celgene or Celgene alliance partner study.Participants will be monitored over time to assess the effects of the gene-modified T …
UPCC 33418 Managed Access Program (MAP) Cohort Treatment Plan CCTL019B2003I to Provide Access for Patients With Out of Specification Leukapheresis Product and/or Out of Specification Manufactured Tisagenlecleucel (CTL019; Kymriah®)
All genders
This study investigates providing access to an investigational medication for patients with serious or life-threatening conditions where standard treatments are not suitable. The study focuses on patients with out-of-specification leukapheresis products or out-of-specification manufactured cells for treatment. Leukapheresis is a procedure that involves removing white blood cells from the body, …
99 years or below
All genders
mNET is commonly treated with TACE or TACE. mNET cells can survive TACE or TARE ischemic conditions. In this study, we will biopsy mNETs being treated with TACE or TARE prior to treatment, after treatment, and again at recurrence to characterize the metabolic, immunologic, and genetic profile of the cells …
18 years - 99 years
All genders
The main purpose of this study is to determine if certain genes, hormones, or other factors predict the risk of developing lung vessel disease in patients with liver disease and whether they determine outcome. Patients in need of a liver transplant evaluation or have portopulmonary hypertension or are suspected of …
99 years or below
All genders
The purpose of this research study is to collect clinical information and biologic specimens from patients receiving CAR T cells and other cancer immunotherapies. The clinical information and biologic specimens will be used to better understand how these therapies work to treat cancer and how they affect patients immune systems.
341 - 350 of 938